+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

R

Actively Recruiting

Researchers are collecting and analyzing real-world data from multiple centers in Italy and Poland on the use of the PERCUTEK Tycheseal stent-graft system for repairing abdominal aortic aneurysms AAA. The study aims to evaluate the technical success, safety, and mid-term outcomes of this device in actual clinical practice. It focuses on patients with suitable anatomy undergoing this procedure, to provide evidence on the devices performance and related complications over time. This is an observational, physician-initiated registry enrolling 120 to 200 patients over about 18 months. Participants receive the PERCUTEK Tycheseal tri-modular endograft system, which includes a main body and two iliac limbs designed to fit a range of aortic anatomies. The device features a low-profile delivery system and radiopaque markers to aid placement. Data on the procedure and outcomes are collected without experimental treatments or randomization. Participants are followed for up to 24 months after device implantation with assessments at baseline, discharge, 1 month, 12 months, and 24 months. Study measures include technical success defined by proper device positioning and no immediate serious leaks, aneurysm size changes, endoleak presence, device migration or occlusion, and major adverse events. Data are collected using standardized forms, and safety outcomes are monitored throughout the study period to understand the devices mid-term clinical performance.

Age: 18Years +All Genders
26 locations
G

Actively Recruiting

The VISTA Nova Study focuses on patients with aortic stenosis who are undergoing transcatheter aortic valve replacement TAVR. The goal is to assess the safety, performance, and long-term durability of the Navitor valve in a real-world setting. This observational study evaluates how well the device works and its impact on patient outcomes over time. Participants will receive the Navitor Transcatheter Aortic Valve using the FlexNav delivery system and the Navitor Loading System. The Navitor valve comes in five sizes to fit annulus diameters from 19 mm to 30 mm, and the delivery and loading systems are available in two sizes each. The procedure follows approved indications and involves specialized equipment to implant the valve. During the study, participants will be monitored at scheduled follow-up visits after their TAVI procedure to track outcomes such as overall survival and valve leakage. The primary outcomes measured include all-cause mortality and the presence of moderate or greater paravalvular leak at 30 days post-procedure. Participants are expected to return for all required follow-up visits to help researchers evaluate the valves long-term safety and effectiveness, with the study continuing through 2032.

Age: 18Years - 100YearsAll Genders
50 locations
C

Actively Recruiting

Researchers are evaluating the TES HT100 device as a non-invasive tool to identify intracranial abnormalities in adult emergency department patients who have mild head trauma or neurological symptoms unrelated to trauma that are not immediately life-threatening. This study aims to compare the accuracy and safety of the TES HT100 device with head CT scans, the current standard for detecting brain injuries. It also explores whether TES HT100 could support better patient triage and resource use in emergency settings. Participants will receive usual emergency care, including a head CT scan, and undergo an additional TES HT100 examination lasting about 5 minutes. The TES HT100 uses ultra-low-power, non-ionizing electromagnetic waves to detect brain abnormalities and provides a simple yesno result. The device examination is performed by trained staff and is done within 24 hours before or after the CT scan. The study plans to enroll approximately 850 adults across three centers in Italy and Poland over 30 months. During the study, participants will have their TES HT100 results compared to their CT reports to assess diagnostic accuracy. Safety monitoring will track any adverse events related to the TES HT100 device throughout the participation, which lasts about one year on average. Researchers will also collect information on the time, procedures, and costs related to TES HT100 use. The overall goal is to gather evidence on TES HT100s performance and safety as a rapid screening tool in emergency care.

Age: 18Years +All GendersPhase Not Applicable
3 locations
P

Actively Recruiting

Researchers are evaluating the clinical safety and performance of the MicroPort CardioFlow VitaFlow Liberty17 Transcatheter Aortic Valve System in patients with severe aortic valve stenosis who are at high risk for surgical valve replacement. This is a prospective, single-arm, multi-center, observational study that follows patients receiving this device in routine clinical practice. The main goal is to document the combined rate of death from any cause and stroke with disability 12 months after the procedure. Participants will undergo transcatheter aortic valve replacement using the VitaFlow Liberty device. The study follows patients through standard care visits including screening, the valve replacement procedure, hospital discharge, and follow-up appointments. These visits are conducted according to local medical practices. The single-arm design means all participants receive the device, with no comparison group or placebo. During the study, participants will have exams and assessments at screening, procedure, discharge, and follow-up visits. Researchers will measure outcomes such as survival, stroke incidence, valve function, safety events, and heart function using standard clinical tools. The study includes monitoring at various time points up to 5 years to assess device success, safety, and valve performance. Participation duration extends through these scheduled follow-ups to capture long-term results.

Age: 18Years +All Genders
9 locations